United-Guardian Inc(UG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 13.36 | EPS (ttm) | 0.54 | Insider Own | 35.65% | Shs Outstand | 4.6M | Perf Week | 1.41% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 3.0M | Perf Month | -1.1% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 19.24% | Short Float | 0.54% | Perf Quarter | 2.14% |
| Income | 0.00B | P/S | 2.94 | EPS this Y | - | Inst Trans | -1.22% | Short Ratio | 1.89 | Perf Half Y | 9.46% |
| Sales | 0.01B | P/B | 2.83 | EPS next 5Y | - | ROA | 18.27% | Short Interest | 0.02M | Perf YTD | 16.4% |
| Book/sh | 2.53 | P/C | 3.43 | EPS past 3/5Y | -6.42% -8.62% | ROE | 21.35% | 52W High | -15.65% ($8.50) | Perf Year | -12.56% |
| Cash/sh | 2.09 | P/FCF | 9.69 | Sales past 3/5Y | -6.01% -0.82% | ROIC | 21.2% | 52W Low | 28.6% ($5.58) | Perf 3Y | -5.78% |
| Dividend Est. | $0.55 (7.67%) | EV/EBITDA | 9.53 | EPS Y/Y TTM | -3.58% | Gross Margin | 46.38% | Volatility(W/M) | 3.22% 3.69% | Perf 5Y | -51.49% |
| Dividend TTM | 0.55 | EV/Sales | 2.08 | Sales Y/Y TTM | 3.23% | Oper. Margin | 20.82% | ATR (14) | 0.27 | Perf 10Y | -53.93% |
| Dividend Ex-Date | 2026/7/28 | Quick Ratio | 6.64 | EPS Q/Q | 16.28% | Profit Margin | 22% | RSI (14) | 49.68 | Recom | - |
| Dividend Gr. 3/5Y | -4.09% -5.11% | Current Ratio | 7.32 | Sales Q/Q | 9.51% | SMA20 | 0.39% ($7.14) | Beta | 0.95 | Target Price | - |
| Payout | 130.92% | Debt/Eq | 0 | Earnings | - | SMA50 | -1.43% ($7.27) | Rel Volume | 0.5 | Prev Close | $7.19 |
| Employees | 25 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 5.71% ($6.78) | Avg Volume(3M) | 0.01M | Price | $7.17 |
| IPO | 1980/3/17 | Option/Short | No/Yes | Trades | 82 | Volume | 4,266 | Change | -0.28% |
Company
UG is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
United-Guardian is a small specialty chemical company headquartered in Hollywood, New York, USA. It manufactures and sells cosmetic ingredients, pharmaceuticals, medical lubricants, and wellness products from its in-house research laboratory. Its core business is the B2B supply of its flagship "Lubrajel" hydrogel ingredient to global cosmetic and medical device companies.
Over the past 1 year, roughly in the middle
16% below its 1-year high.
UG makes money exceptionally well
20.82% of revenue is kept as operating profit.
Tap to view numbers
The price looks about right
Trading at 13.4 times earnings.
Tap to view numbers
Holding long would have lost money
Would have changed by -5.8% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 7.67% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 19.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #4 in the industry
Based on market cap of $33M.
FAQ
What kind of company is UG?
UG belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of UG?
The market cap of UG is approximately $33M, ranking 5,108 within its sector.
Does UG pay dividends?
UG has a dividend yield of approximately 7.67%, with an annual dividend of $0.55.
What is the P/E ratio of UG?
UG has a P/E ratio of approximately 13.4x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for UG?
UG has recorded a 52-week high of $8.50 and a low of $5.58.